OpenBilldrug price receipt

NADAC week of 2026-10-14

AMLODIPINE BESYLATE 10 MG TAB

For 30 tablets

Pharmacies pay

$0.44 filed

30 × $0.01479 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2.54 filed

30 × $0.08478 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.7× estimated

Medicare paid 5.7× what pharmacies pay.

Part D averages every strength and form sold under “Amlodipine Besylate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.51 estimated

$0.44 + $0.07 (15%) + $5.00 fee per fill = $5.51

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMLODIPINE BESYLATE 10 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amlodipine besylate, under the trade name “AMLODIPINE BESYLATE 10 mg”.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals, Inc., Major Pharmaceuticals and Unichem Pharmaceuticals (USA), Inc.

FDA lists it under 2 Established Pharmacologic Classes: Calcium Channel Blocker and Dihydropyridine Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 33 NDCs (National Drug Codes); the FDA directory lists 31 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.44 for 30 tablets (30 × $0.01479 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 14 labelers

LabelerNDCsPharmacies pay per unit
Ascend Laboratories, LLC6$0.01479 per EA filed
Exelan Pharmaceuticals, Inc.4$0.01479 per EA filed
Oxford Pharmaceuticals, LLC3$0.01479 per EA filed
Unichem Pharmaceuticals (USA), Inc.3$0.01479 per EA filed
Cipla USA Inc.2$0.01479 per EA filed
Legacy Pharmaceutical Packaging, LLC2$0.01479 per EA filed
Lupin Pharmaceuticals, Inc.2$0.01479 per EA filed
Mylan Pharmaceuticals Inc.2$0.01479 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.01479 per EA filed
American Health Packaging1$0.01479 per EA filed
Epic Pharma, LLC1$0.01479 per EA filed
Major Pharmaceuticals1$0.01479 per EA filed
Quallent Pharmaceuticals Health LLC1$0.01479 per EA filed
Teva Pharmaceuticals, Inc.1$0.01479 per EA filed
Not listed as a package in the FDA directory2$0.01479 per EA filed
All 33 NDCs, with labeler and price
  • 00480-7168-10 · Teva Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 00480-7168-98 · not listed as a package in the FDA directory · $0.01479 per EA · eff. 2026-09-23 filed
  • 00904-6371-61 · Major Pharmaceuticals · $0.01479 per EA · eff. 2026-09-23 filed
  • 29300-0398-05 · Unichem Pharmaceuticals (USA), Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 29300-0398-10 · Unichem Pharmaceuticals (USA), Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 29300-0398-19 · Unichem Pharmaceuticals (USA), Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 42806-0057-10 · Epic Pharma, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 59762-2135-01 · Mylan Pharmaceuticals Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 59762-2135-09 · Mylan Pharmaceuticals Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 60687-0496-01 · American Health Packaging · $0.01479 per EA · eff. 2026-09-23 filed
  • 60687-0496-11 · not listed as a package in the FDA directory · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0199-05 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0199-10 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0199-90 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0902-05 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0902-10 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 67877-0902-90 · Ascend Laboratories, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 68180-0721-03 · Lupin Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 68180-0721-09 · Lupin Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 68382-0123-05 · Zydus Pharmaceuticals USA Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 68382-0123-16 · Zydus Pharmaceuticals USA Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 68645-0516-54 · Legacy Pharmaceutical Packaging, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 68645-0580-54 · Legacy Pharmaceutical Packaging, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 69097-0128-05 · Cipla USA Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 69097-0128-15 · Cipla USA Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 69584-0023-09 · Oxford Pharmaceuticals, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 69584-0023-50 · Oxford Pharmaceuticals, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 69584-0023-90 · Oxford Pharmaceuticals, LLC · $0.01479 per EA · eff. 2026-09-23 filed
  • 76282-0239-10 · Exelan Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 76282-0239-90 · Exelan Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 76282-0509-10 · Exelan Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 76282-0509-90 · Exelan Pharmaceuticals, Inc. · $0.01479 per EA · eff. 2026-09-23 filed
  • 82009-0028-10 · Quallent Pharmaceuticals Health LLC · $0.01479 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name amlodipine besylate with AMLODIPINE BESYLATE 10 MG TAB.

ProductPharmacies pay per unitMedicare per unit
AMLODIPINE BESYLATE 2.5 MG TAB
generic · tablet
$0.01061 per EA filed
eff. 2026-09-23
$0.08478 per EA filed
Part D 2024 average
AMLODIPINE BESYLATE 5 MG TAB
generic · tablet
$0.01018 per EA filed
eff. 2026-09-23
$0.08478 per EA filed
Part D 2024 average
AMLODIPINE BESYLATE 10 MG TAB this page
generic · tablet
$0.01479 per EA filed
eff. 2026-09-23
$0.08478 per EA filed
Part D 2024 average
NORVASC 2.5 MG TABLET
brand · tablet
$8.70379 per EA filed
eff. 2026-01-01
$9.19968 per EA filed
Part D 2024 average
NORVASC 5 MG TABLET
brand · tablet
$8.69312 per EA filed
eff. 2026-09-23
$9.19968 per EA filed
Part D 2024 average
NORVASC 10 MG TABLET
brand · tablet
$11.94157 per EA filed
eff. 2026-09-23
$9.19968 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 33 NDCs’ NADAC prices is $0.01479 per EA filed.

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 105 have a higher middle NADAC price and 2 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 65 have a higher middle NADAC price and 2 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $2.54 for 30 tablets, at an average of $0.08478 per EA in 2024 (2024-01-01 to 2024-12-31) for “Amlodipine Besylate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 50,204,110 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AMLODIPINE BESYLATE 10 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amlodipine Besylate / Amlodipine Besylate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.